menu
menu
arrow
hexagon-play-button
Take the tour
Open
Access
Offer
hexagon-arrow

Open for
Scientific Users

CERIC offers a free, multidisciplinary open access service for users selected on quality by international competition, offering complementary analytical and modification techniques for nano-level science and technology.

> Learn more

Open for
Industry

CERIC is an innovation ecosystem for industry, offering services and technologies, technical and scientific knowledge and skills, and strong industry expertise, with a strategic outlook in nanotech.

> Learn more

Open for
Media & Public

CERIC is a trading post for Research, Education and Industry, driving innovation in Europe, and responding to multiple challenges by attracting the best capabilities at world level.

> Learn more

Featured

Latest

Save the date for the @BNCHungary #webinar "@EuropeanXFEL, a New User Facility for Fundamental Science on ultra short timescales"

>> 21 October, 13:30-14:20 (CEST)

Speaker: Robert Feidenhans’l, EuXFEL Managing Director

Learn more and connect here >> http://bit.ly/BNCwebinar--EuXFEL

. #SaveTheDate for the last #ACCELERATE2020 webinar on #radiation safety, which will be held on 21 October at 11:30. The speaker will address the conformance to radiation safety regulations when supplying into #ResearchInfrastructures.

Register now ► http://bit.ly/39Z6DfF

About Us

CERIC-ERIC is a multidisciplinary Research Infrastructure open for basic and applied users in the fields of Materials, Biomaterials and Nanotechnology. With a single entry point to excellent facilities in Central and Eastern Europe, it allows structural investigation, analysis and synthesis of materials, using photon, electron, neutron and ion based techniques. It enables the delivery of innovative solutions to societal challenges in the fields of energy, health, food, cultural heritage and more.

> Find out more
9.6.2020

CERIC-ERIC, the superlaboratory open for scientists all over the world

26.8.2020

The DOI for data

10.6.2020

Nano-analytics for Pharmaceutics: interview with Aden Hodzic

Projects and collaborations